In addition to clinical features and morphological characteristics of cells, complete immunophenotypic analysis (including CD11C, CD25, CD103, and CD123) and molecular detection (BRAFV600E mutation) can be differentiated from other HCL-like diseases and achieve accurate diagnosis. Here, ITGAX is linked to hairy cell leukemia.